Hepatitis B vaccination with HepB-CpG in people living with HIV: a narrative review
Introduction To eliminate hepatitis B virus (HBV) globally, a key focus is preventing new infections among high-risk individuals, including those with HIV. The widespread incidence of HBV and HIV leads to a high rate of coinfection. HIV compromises the immune system, significantly increasing the ris...
Saved in:
| Main Authors: | Kelvin McKoy, Stephanie Campbell, Patricia Novy, Robert S. Janssen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Expert Review of Vaccines |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2502643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccines
by: Katia J Bruxvoort, et al.
Published: (2024-12-01) -
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies
by: John M. Hickey, et al.
Published: (2025-12-01) -
DNA Dissipative System for Controlled Release of Immunostimulatory CpG Oligodeoxynucleotides
by: Aman Ishaqat, et al.
Published: (2024-11-01) -
Challenges to implementing mandatory hepatitis B vaccination: bridging immunization gaps among health workers in sub-Saharan Africa
by: Stephen Olaide Aremu, et al.
Published: (2025-03-01) -
A novel trivalent inactivated Salmonella vaccine formulated with CpG ODNs to enhance the cellular immunity in chickens
by: Tamer Kahraman, et al.
Published: (2025-05-01)